Medical Director of the Nationwide Children’s Hospital Hemostasis and Thrombosis Center Bryce A. Kerlin, MD, has joined the Center for Clinical and Translational Research. His research is focused on the translational epidemiology of pediatric thrombosis, focusing on the elucidation of biomarkers and clinical characteristics associated with thrombosis, especially in pediatric kidney disease. He actively participates in clinical trials for new treatments in hemostasis and thrombosis, including new medications for hemophilia, von Willebrand disease, and blood clots.
myChildren’s mobile app
iPhone and Android.